Fractal Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Fractal Therapeutics, based in Lexington, Massachusetts, operates in biotechnology research with a focus on drug discovery and development driven by modeling. The firm treats modeling as a decision-making tool whose outputs propel programs forward quickly and cost-effectively, rather than as an end product. It combines mathematical modeling with carefully designed animal studies and early clinical work to help clients determine the best path for development. Working with pharmaceutical and biotech partners, Fractal builds preclinical and early-clinical pharmacology packages that address key questions such as asset identification, feasibility of the intended product profile, and how to reach the next value inflection point. Its services may include designing or managing studies, interpreting modeling outcomes, and summarizing findings for regulatory submissions and investor materials. Within the biotechnology landscape, the firm presents itself as a precise, evidence-based collaborator focused on rigorous decision-making to minimize wasted time and cost.